Front row L to R: Steven Pepe, David Chun, Jim Davis; back row L to R: Matthew Shapiro and Kevin Post

18 September 2025NewsCareersSarah Speight

Ropes & Gray loses 21-attorney group to join rival on growth spree

The exodus of patent trial litigators was ‘an easy choice’ due to their new employer’s ‘scale, vision and entrepreneurial culture’.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Careers

Former USPTO acting director takes the helm at C4IP

17 August 2026 The IP advocacy group has turned to former USPTO acting director Coke Morgan Stewart as it enters what it calls a “new chapter”.

Careers

Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie

13 August 2026 Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech—in the US.

Careers

Former senior attorney-advisor to ITC commissioners joins Mintz

7 August 2026 After more than 14 years at the US International Trade Commission, the new hire says he was drawn to Mintz for its “continued growth in the life sciences sector”.

More features

Former USPTO acting director takes the helm at C4IP

Europe’s missing biotech bridge: Why IP ownership matters more than capital access

Novartis scores UK win in high-stakes Entresto fight

Invisalign maker secures first China win against clear aligner rival

Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

Lilly mounts defence as generics circle Mounjaro and Zepbound

Ropes & Gray loses 21-attorney group to join rival on growth spree

More on this story

Editor's picks

Editor's picks

More features